Skip to main navigation Skip to search Skip to main content

Tildacerfont for the Treatment of Patients With Classic Congenital Adrenal Hyperplasia: Results From a 12-Week Phase 2 Clinical Trial in Adults With Classic CAH

  • Richard Joseph Auchus
  • , Deborah P Merke
  • , Ivy-Joan Madu
  • , Samer Nakhle
  • , Kyriakie Sarafoglou
  • , Michael Huang
  • , David Moriarty
  • , Chris Barnes
  • , Ron S Newfield
  • University of Michigan
  • National Institutes of Health
  • Diabetes Associates Medical Group, Orange, CA, USA
  • Palm Medical Group, Las Vegas, NV, USA
  • University of Minnesota
  • former employee of Spruce Biosciences, Daly City, CA, USA
  • Spruce Biosciences, Daly City, CA, USA
  • University of California, San Diego

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalJournal of the Endocrine Society
Volume5
DOIs
StatePublished - May 3 2021
Externally publishedYes

Disciplines

  • Medicine and Health Sciences
  • Pediatrics

Cite this